Alg13tm1e(KOMP)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Alg13tm1e(KOMP)Wtsi |
| Name: |
asparagine-linked glycosylation 13; targeted mutation 1e, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:4841285 |
| Gene: |
Alg13 Location: ChrX:143100962-143157446 bp, + strand Genetic Position: ChrX, 65.42 cM, cytoband F2
|
| IMPC: |
Alg13 gene page |
|
| Mutant Cell Line: |
EPD0161_5_H06 |
| Germline Transmission: |
Unknown
|
| Parent Cell Line: |
JM8.N4 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
| Project Collection: |
KOMP-CSD
|
|
| Allele Type: |
|
Targeted (Null/knockout, Reporter) |
| Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 143122231 of Chromosome X upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. Insertion of this cassette creates a reporter knockout mouse. Cre expression will remove the neomycin selection cassette. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:148605, J:173534)
|
|
|
|
|
| Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
| All: |
2 reference(s) |
|
Analysis Tools
